insulin drugs glp 1 receptor agaonist market GLP-1 Agonist Size, Trends and Share Report 2026 GLP-1 Receptor Agonist Market Size
Description
(Lausanne) 13 , 846903 (2022)
Kim MK, Baek KH, Song KH, Il Kang M, Park CY, Lee WY, et al
Researchers found that GLP-1 signaling directly correlated with the decrease of pro-inflammatory cytokine production, which includes tumor necrosis factor-alpha (TNF-) and interleukin-6 (IL-6)
As per FMI, the market's valuation is increasingly uncoupled from diabetes prevalence alone, driven by regulatory endorsement of weight management indications and cardiovascular risk reduction claims that expand the addressable patient population by an order of magnitude [1]
Benito E, Blazquez E, Bosch MA
By week 12, average systolic blood pressure drops 4-6 points, with some individuals seeing more dramatic reductions
